Mounjaro is a once-weekly injection for type 2 diabetes. Its label sets a starting dose of 2.5 mg and a maximum of 15 mg for adults [1]. Where you land in between depends on your blood sugar and how you tolerate it, and that's decided with your prescriber. This page covers what the label fixes and what each number means for you.
Mounjaro comes in six strengths, from 2.5 mg to 15 mg
Every Mounjaro form comes in the same six strengths [1]. The single-dose pen and single-dose vial hold one dose each. The multi-dose vial and the KwikPen each hold four doses of one strength.
| Strength | Single-dose pen or vial | Multi-dose vial or KwikPen |
|---|---|---|
| 2.5 mg | Yes | Yes, 4 doses |
| 5 mg | Yes | Yes, 4 doses |
| 7.5 mg | Yes | Yes, 4 doses |
| 10 mg | Yes | Yes, 4 doses |
| 12.5 mg | Yes | Yes, 4 doses |
| 15 mg | Yes | Yes, 4 doses |
Mounjaro prescribing information, section 3 [1]. Which form you get depends on your prescription and pharmacy.
Everyone starts at 2.5 mg, to spare the stomach
The label's recommended starting dosage is "2.5 mg injected subcutaneously once weekly" for everyone [1]. It explains the slow start plainly: the starting dose and gradual increases are there "to reduce the risk of gastrointestinal adverse reactions."
The label calls 2.5 mg the starting dosage. It also prints a modeling estimate: "exposure-response analyses integrating phase 2 and phase 3 efficacy data predict that after 52 weeks, tirzepatide 2.5 mg administered once weekly may reduce HbA1c by approximately 1.8%" [1]. That's a prediction from a model, not a trial result, and the label still treats 2.5 mg as where treatment begins.
The dose goes up only if blood sugar needs it
Mounjaro's label raises the dose "if additional glycemic control is needed" [1]. That's the key difference from a weight-loss label: the trigger is your blood sugar, not a fixed climb. So the label doesn't require everyone to reach 15 mg.
The label also sets the pace and the size of each step. This page doesn't list them, because the right steps for you depend on your numbers and your side effects, and your prescriber and the pen's instructions cover them. For how the same steps work on the weight-loss brand, see Zepbound dosage.
The maximum is 15 mg for adults and 10 mg for children
The label's ceiling is 15 mg once weekly for adults and 10 mg once weekly for children 10 years and older [1]. Mounjaro's labeled uses are blood sugar control in type 2 diabetes, alongside diet and exercise, and lowering the risk of heart attack, stroke and cardiovascular death in adults with type 2 diabetes at high risk of them.
Higher doses didn't lower blood sugar much more in Mounjaro's first trial. In SURPASS-1, a 40-week trial of Mounjaro alone, HbA1c fell by 1.8 points on 5 mg and 1.7 on both 10 and 15 mg, against 0.1 on placebo [1]. Weight loss rose a little with dose.
| Group | HbA1c change | Reached HbA1c under 7% | Weight change |
|---|---|---|---|
| Placebo | −0.1 | 23% | −2.2 lb (−1.0 kg) |
| 5 mg | −1.8 | 82% | −13.9 lb (−6.3 kg) |
| 10 mg | −1.7 | 85% | −15.4 lb (−7.0 kg) |
| 15 mg | −1.7 | 78% | −17.2 lb (−7.8 kg) |
Mounjaro prescribing information, Table 4 [1]. Pounds converted from the label's kilograms by our arithmetic.
Once a week, any time of day, with or without food
The label says to take Mounjaro "once weekly, any time of day, with or without meals" [1]. That's the whole timing rule for most people. Questions about a late or missed dose have specific answers on the label; ask your prescriber or pharmacist rather than guessing. The pen or vial's instructions, and the training your prescriber arranges, cover how to use it.
Mounjaro and Zepbound share doses but not uses
Zepbound is the same drug, tirzepatide, in the same strengths and the same 15 mg maximum. The difference is what each is approved for and how the label picks a dose [2].
| Mounjaro | Zepbound | |
|---|---|---|
| Approved for | Type 2 diabetes (blood sugar; heart risk) | Weight management; obstructive sleep apnea with obesity |
| Starting dose | 2.5 mg weekly | 2.5 mg weekly |
| Ongoing dose | Raised if blood sugar needs it | 5, 10 or 15 mg for weight; 10 or 15 mg for sleep apnea |
| Maximum | 15 mg (adults); 10 mg (children 10+) | 15 mg |
Mounjaro and Zepbound prescribing information, sections 1 and 2 [1] [2].
For everything else that differs, from coverage to price, see Zepbound vs Mounjaro. For the semaglutide alternative for diabetes, see Ozempic vs Mounjaro.
A higher dose doesn't cost more on LillyDirect
Lilly's self-pay pharmacy lists the Mounjaro single-dose pen at "Starting at $499/month" for every strength, 2.5 mg through 15 mg [3]. So moving from 5 mg to 15 mg doesn't change the self-pay bill. Insurance, the savings card and Medicare are covered in Mounjaro cost.
Stomach side effects rose with the dose
In Mounjaro's placebo-controlled trials, nausea was reported by 12% on 5 mg, 15% on 10 mg and 18% on 15 mg, against 4% on placebo [1]. Diarrhea, vomiting and reduced appetite followed the same pattern. That's the reason for the slow start.
| Effect | Placebo | 5 mg | 10 mg | 15 mg |
|---|---|---|---|---|
| Nausea | 4 | 12 | 15 | 18 |
| Diarrhea | 9 | 12 | 13 | 17 |
| Decreased appetite | 1 | 5 | 10 | 11 |
| Vomiting | 2 | 5 | 5 | 9 |
| Constipation | 1 | 6 | 6 | 7 |
Mounjaro prescribing information, Table 1 [1].
The full picture is in tirzepatide side effects and is Mounjaro safe? If you've noticed you're urinating more, see does Mounjaro make you pee more? The molecule itself is on the tirzepatide guide.